Manifest your mind

We are on a mission to enhance the wellbeing of society.

Our CompaniesContact Us

Optimizing the human experience

Levitee Labs specializes in developing and acquiring integrated wellness assets that provide access to the compounds and alternative medicine that improve and transform wellbeing. 

Our Companies →

Created with you
in mind

Leveraging synergies across specialties to innovate wellness solutions. With the help of our advisors, our executive team is strategically building our scientific advisory board. 

Our Team →

World changing tools that create impact

Levitee Labs envisions a future where people globally have the power of choice when discovering integrated wellness tools for elevating and healing.

Our Approach →

download our
corporate presentation

Our Investor Relations team is available on demand to answer all your questions. Download our deck to get powerful insights in our markets and aims.

Download Now

Talk to our Investor relations team

Our Investor Relations team is available on demand to answer all your questions. Download our deck to get powerful insights in our markets and aims.

Contact Us

Preventative | Restorative | Transformative

There is a powerful human ability to heal and elevate oneself when there is  access to the transformative benefits of standardized and quality-controlled integrated wellness tools.

Manifest your mind

We are on a mission to enhance the wellbeing of society.

Our CompaniesContact Us

a portfolio of market innovating ventures

Levitee Labs has established a profitable portfolio of integrated wellness assets to fund advancements in alternative medicine and psychedelic pharmacology.

Our Companies

created by leaders,
for leaders

Directed by the world’s leading experts in psychedelic treatment, Levitee’s leadership team is currently engaging leading universities and researchers to develop novel psychedelic compounds, delivery mechanisms, and therapies.

Meet our Team

world changing ideas that create impact

Levitee is powered by innovation, and exploring new and emergent markets is our speciality.



Read More

download our
corporate presentation

Our Investor Relations team is available on demand to answer all your questions. Download our deck to get powerful insights in our markets and aims.

Download Now

Talk to our Investor relations team

Our Investor Relations team is available on demand to answer all your questions. Download our deck to get powerful insights in our markets and aims.

Contact Us

25%

of the population currently suffers from mental health or neurological disorders.[1]

50%

increase in prescribing rates for prescription opioids among adolescents and young adults nearly doubled from 1994-2007.[1]

80%

of new heroin users started out misusing prescription painkillers.[2]

46%

increase in success when comparing psychedelic psychotherapy vs. conventional addiction approaches.[3]

792 million

People globally living with a mental health or substance use disorder

264 million

People suffering from depression

264 million

People suffering from anxiety

71 million

People suffering from drug use disorder with only 20% receiving treatment

550 million

Work days lost due to stress

27 million

People suffering from chronic fatigue

800,000

Deaths by suicide each year

$1 Trillion USD

Estimated global economic cost of depression and anxiety

25%

of the population currently suffers from mental health or neurological disorders.[1]

50%

increase in prescribing rates for prescription opioids among adolescents and young adults nearly doubled from 1994-2007.[1]

80%

of new heroin users started out misusing prescription painkillers.[2]

46%

increase in success when comparing psychedelic psychotherapy vs. conventional addiction approaches.[3]

Start a conversation with us

Every day we’re catalyzing transformative wellness and advancing access to psychedelic compounds

Visit our Investors Page →Reach Out →

25%

of the population currently suffers from mental health or neurological disorders.[1]

50%

increase in prescribing rates for prescription opioids among adolescents and young adults nearly doubled from 1994-2007.[1]

80%

of new heroin users started out misusing prescription painkillers.[2]

46%

increase in success when comparing psychedelic psychotherapy vs. conventional addiction approaches.[3]

Join Levitee Labs

We are looking to hire dynamic individuals with diverse scientific, operational and medical expertise. 

Careers →

News

Download our Corporate Presentation

Please enter your information below to get access to our full corporate presentation.
LeviteeLabs-Investor-Deck.pdf
Download Now
Oops! Something went wrong while submitting the form.
+